BackLilly(Eli) Overview
Lilly(Eli) & Co

Lilly(Eli) Target Price

See Lilly(Eli)'s analyst price targets ($1.4K) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1,437.76

Average Target Price

$1430.210.5% downside

24 analysts in the last 4 months

High: $1650 | Low: $940

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-11-02Cantor FitzgeraldCarter Gould$1,60011.3% upsideOpen
2026-10-30BMO CapitalEvan Seigerman$1,65014.8% upsideOpen
2026-10-30Wells FargoMohit Bansal$1,5004.3% upsideOpen
2026-10-30Argus ResearchJasper Hellweg$1,5507.8% upsideOpen
2026-10-30RBC Capital$1,60011.3% upsideOpen
2026-10-30KeyBanc$1,4974.1% upsideOpen
2026-10-30UBSMichael Yee$1,62513% upsideOpen
2026-10-30Truist FinancialSrikripa Devarakonda$1,61212.1% upsideOpen
2026-10-26BernsteinCourtney Breen$1,4500.9% upsideOpen
2026-10-21Leerink Partners$1,3168.5% downsideOpen
2026-10-20Goldman Sachs$1,4131.7% downsideOpen
2026-10-08Cantor FitzgeraldCarter Gould$1,4400.2% upsideOpen
2026-10-07Morgan Stanley$1,4300.5% downsideOpen
2026-09-18GuggenheimSeamus Fernandez$1,28410.7% downsideOpen
2026-09-15Berenberg BankKerry Holford$1,4002.6% downsideOpen
2026-09-10HSBC$94034.6% downsideOpen
2026-08-07UBS$1,3764.3% downsideOpen
2026-08-06Morgan Stanley$1,4191.3% downsideOpen
2026-08-06Cantor Fitzgerald$1,4101.9% downsideOpen
2026-08-06BMO CapitalEvan Seigerman$1,4002.6% downsideOpen
2026-08-06Wells FargoMohit Bansal$1,3307.5% downsideOpen
2026-07-14Bernstein$1,3853.7% downsideOpen
2026-07-13UBS$1,4250.9% downsideOpen
2026-07-13Guggenheim$1,27311.5% downsideOpen
2026-07-09UBS$1,3704.7% downsideOpen
2026-07-08Truist Financial$1,3704.7% downsideOpen
2026-07-08Morgan StanleyTerence Flynn$1,3476.3% downsideOpen
2026-07-08RBC Capital$1,5004.3% upsideOpen
2026-07-06Cantor Fitzgerald$1,3506.1% downsideOpen
2026-06-25Leerink PartnersDavid Risinger$1,23214.3% downsideOpen
2026-06-22Berenberg BankKerry Holford$1,13521.1% downsideOpen
2026-06-09Jefferies$1,3506.1% downsideOpen
2026-05-26HSBC$1,25113% downsideOpen
2026-05-26Leerink PartnersDavid Risinger$1,11922.2% downsideOpen
2026-05-21Wolfe Research$1,3506.1% downsideOpen
2026-05-05BarclaysEmily Field$1,4002.6% downsideOpen
2026-05-01Morgan Stanley$1,3446.5% downsideOpen
2026-05-01Cantor FitzgeraldCarter Gould$1,23014.4% downsideOpen
2026-04-10Morgan Stanley$1,3277.7% downsideOpen
2026-03-13JefferiesAkash Tewari$1,3009.6% downsideOpen
2026-03-06Deutsche BankJames Shin$1,28510.6% downsideOpen
2026-03-05Morgan StanleyTerence Flynn$1,3138.7% downsideOpen
2026-02-24RBC CapitalTrung Huynh$1,25013.1% downsideOpen
2026-02-19Barclays$1,3506.1% downsideOpen
2026-02-10Loop Capital MarketsIlya Zubkov$1,20016.5% downsideOpen
2026-02-05BMO CapitalEvan Seigerman$1,3009.6% downsideOpen
2026-02-05Wells FargoMohit Bansal$1,28011% downsideOpen
2026-02-05Goldman Sachs$1,26012.4% downsideOpen
2026-02-05Truist Financial$1,28110.9% downsideOpen
2026-02-05Scotiabank$1,3009.6% downsideOpen

Lilly(Eli) (LLY) FAQ

Lilly(Eli) (LLY) currently reports a target price of $1.4K. Use the charts on this page to explore Lilly(Eli)'s target price history and peer comparisons.

Analysts' average 12-month price target for Lilly(Eli) is $1.4K, about 0.5% downside from the current share price of $1437.76. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $1.4K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lilly(Eli), and consider following LLY for alerts when major investors trade the stock.

Lilly(Eli) is classified in the Healthcare sector. On target price, it currently shows $1.4K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LLY with unrelated industries.